news
Imfinzi combination fails advanced lung cancer study
A late-stage clinical trial for Imfinzi and an experimental treatment has not extended the lives of patients with advanced non-small cell lung cancer.
List view / Grid view
Lung cancer
news
NICE endorses dacomitinib for treatment of lung cancer
Vizimpro (dacomitinib) has been recommended as a first-line treatment option for patients with lung cancer.
news
Decision by NICE for the use of osimertinib to be appealed
A pharmaceutical company will appeal a decision by NICE to not recommend osimertinib for use within NHS England.
news
Detecting early-stage lung cancer when surgical cure is possible
A method using blood tests could enable clinicians to detect and diagnose early-stage lung cancer in order that surgery could be used as a treatment...
news
Durvalumab improves survival of non-small cell lung cancer patients
Moffitt researchers conducted a Phase III trial which found durvalumab to increase the survival of patients with non-small cell lung cancer...
news
Pioneering radiotherapy machine treats its first patient in the UK
Improved accuracy and fewer patient side effects are among the benefits claimed for the pioneering radiotherapy machine...
news
Saliva diagnostics: Will saliva translate into a real diagnostic tool?
Saliva has been used to measure stress hormones, enzyme levels and cancer mutations...
news
Watson system increases clinical trial enrolment by 80 percent
Watson for Clinical Trial Matching, an AI platform, has shown an increase of 80 percent in enrolment for breast cancer clinical trials, along with reduced screening times for patients...
news
Blood test shows potential for early detection of lung cancer
A test that analyses free-floating DNA in the blood may be able to detect early-stage lung cancer...
news
Nivolumab reduces size of some lung cancer tumours, relapse rate after surgery
A drug given to early-stage lung cancer patients before they undergo surgery showed major tumour responses in the removed tumour...
news
Two-drug combination proves effective for most lung cancers
New study suggests that using a two-drug combination of currently available treatment could be more effective for most lung cancers.
news
RNA-based therapy cures lung cancer
By turning down the activity of a specific RNA molecule, researchers have cured lung tumours in mice...
news
Nanoshells could deliver more chemo with fewer side effects
In vitro study verifies method for remotely triggering release of cancer drugs...
news
Tarloxitinib puts tumour-seeking tail on anti-EGFR drug to target lung cancer
Researchers have proposed a unique way to reach the concentration of anti-EGFR drug needed to fight exon 20 insertions without harming healthy tissues...
news
Alcohol aversion drug disulfiram may combat chemotherapy resistance
Alcohol aversion drug disulfiram may combat chemotherapy resistance in non-small cell lung cancer...
